摘要：One hundred and thirty-eight (138) patients, with five hundred and sixty-six (566) different burn sites with different degrees, severity and locations, were enrolled to a multicenter clinical trial at 25 study centers. The goal of this trial was to evaluate the efficacy of MEBO (Moist Exposed Burn Ointment) in the treatment of burn wound. Various parameters were studied including: (i) healing time, (ii) need for pain killers, (iii) consumption of i. v. Fluids, (iv) use of systemic antibiotics and (v) aesthetic appearance. There was remarkable decrease in the healing time and most patients either did not need any pain killer or were relieved with only mild analgesics, except in few cases of deep second degree and third degree burns. A decrease in the volume of i. v. fluids needed was also reported. Only 19% of cases developed clinical infection, especially in those who were not treated with MEBO immediately post burn. Even though systemic antibiotic treatment was prophylactically implemented in most cases as a routine measure, 32 cases did not receive any antibiotic prophylaxis with MEBO and yet did not develop any infection. The aesthetic appearance reported was very acceptable. This treatment modality was not associated with any side effects, and patient discomfort during application and change was negligible. Thus, MEBO treatment was associated with excellent and relatively faster healing, low incidence of wound infection, and excellent patient compliance.
摘要：Burn injuries are associated with anatomically within physiologically infections and biochemically within immunologically defect in hepatic functions during direct action on locally and systematic role of blood elements and liver enzymes. These defects represented the cellular response due to burn injuries. Aim of study: to assess the treatment and antioxidant action of MEBO ointment in medical therapy ,such as burn therapy. Methods: The study was performed by 66 burn patents(male) received treatment with ointment MEBO(100g)twice daily for two weeks and all patients have thickness burn injury, age ranged(15-65years for all subjects) and 50 men healthy control subjects ,So one day post burn samples were collected for hematological &biochemical parameters in kirkuk city at Azaadi hospital ,and this study done from march to December 2019 . Results: Leukocytes count (WBC), Neutrophil, lymphocyte,) and erythrocyte sedimentation rate ( ESR) were increased, while red blood cells count (RBC), hemoglobin (HB) were decreased after burn injury. Creatinine and potassium element are increased significantly, while Sodium element was decreased and significantly increased in the liver enzyme and glutathione after treatment when MDA significantly decreased .Conclusion: This study concluded that blood parameters and liver functions were altered due to burn injuries and these modulations attributable to the lipid peroxidation(MDA), while the liver enzyme signaling of hepatic activity for glutathione synthesis for curbing the free radicals after treatment by MEBO ointment ,this productive mechanism may be new defect liver mechanism for burn injury.
摘要：The present study aimed to compare between the use of platelet rich fibrin membrane (PRFM) and MEBO scar ointment for cutaneous wound healing as a model treatment. For this reason, forty two local breed rabbits have been divided into four groups, the first three groups were subjected to full thickness skin wound using biopsy punch instrument (diameter 8 mm) on the dorsal thoracic side. Rabbits in the first group leaved without treatment, while in the second group we planted the PRFM in biopsy site, the third group treated with MEBO scarointment. Wound healing process was observed grossly and microscopically at day 3, 7, 10 and 12 post operation.All groups showed normal healing process with competitive advantage to PRFM and MEBO groups respectively compared with untreated group, PRFM was better than the MEBO group, the advantage characterized by less inflammatory reaction, fast reepitheliazation, granulation tissue formation, fibroplasias, and angiogenesis.